Research and analysis

PGT - July 2023 statement

Statement from the Advisory Committee on Novel Foods and Processes (ACNFP) on data requirements for the safety assessment of precision bred organisms (PBOs).

• From: Advisory Committee on Novel Foods and Processes
• Published: 8 September 2023

Documents

Statement of the Advisory Committee on Novel Foods and Processes (ACNFP) on Precision Bred Organisms (PBOs) - Model options and data requirements for triage and tier assignment of PBOs - July 2023

HTML

Statement of the Advisory Committee on Novel Foods and Processes (ACNFP) on Precision Bred Organisms (PBOs) - Model options and data requirements for triage and tier assignment of PBOs - July 2023

PDF, 887 KB, 46 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email acnfp@food.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

DOI: https://doi.org/10.46756/sci.fsa.amp182

This page publishes a statement from the Advisory Committee on Novel Foods and Processes (ACNFP) on precision bred organisms, issued in July 2023. The statement was developed to support the Food Standards Agency (FSA) in its policy development for precision breeding and sets out scientific considerations on the types of information and evidence needed for the safety assessment of precision bred organisms (PBOs) intended for food and feed use. The Products of Genetic Technologies (PGT) Subcommittee supported the ACNFP with this work, building on earlier advice for a proportionate, two‑tier approach to assessment based on novelty, composition and potential safety concerns. The statement addresses the third phase of work commissioned by the FSA, focusing on the determination of appropriate data requirements for PBO safety assessments. It presents two evidence‑based model options, reflecting different levels of scrutiny depending on risk, and outlines how information on novelty, exposure and potential hazards should be considered proportionately. The document provides the scientific rationale for these approaches and supports further development of policy in this area.

Published 8 September 2023